# OnCo record courtney-dinardo (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/courtney-dinardo/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "courtney-dinardo" ;
  schema:name "Courtney D. DiNardo"@en ;
  schema:description "Led VIALE-A, which made venetoclax plus azacitidine the standard for older patients with acute myeloid leukaemia."@en ;
  schema:url <https://onco.cc/people/courtney-dinardo/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=DiNardo%20CD%5BAuthor%5D%20venetoclax%20azacitidine> ;
  onco:tag "aml", "venetoclax", "trialist" ;
  schema:jobTitle "Professor of Leukemia, MD Anderson Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0001-9003-0390> ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:targets <https://onco.cc/targets/bcl2/>, <https://onco.cc/targets/idh/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/> ;
  onco:institutions <https://onco.cc/institutions/md-anderson/> ;
  onco:trials <https://onco.cc/trials/viale-a/>, <https://onco.cc/trials/agile/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-viale-a-venetoclax-azacitidine-nejm-2020/>, <https://onco.cc/key-papers/paper-agile-ivosidenib-azacitidine-nejm-2022/> ;
  schema:affiliation <https://onco.cc/institutions/md-anderson/> .
